Navigation Links
N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency
Date:1/16/2009

TOLEDO, Ohio, Jan. 16 /PRNewswire/ -- N-Viro International Corporation, (OTC Bulletin Board: NVIC), an environmental and materials operating company that owns patented technologies to convert various types of waste into beneficial alternative fuel products, announces its renewable biofuel technology, N-Viro Fuel(TM), has satisfied guidelines set forth by the U.S. Environmental Protection Agency (EPA) to qualify as an alternative energy source that may be utilized in commercial power generation.

Attaining this status means that N-Viro Fuel technology is now eligible to qualify for certain economic incentives that are granted alternative energy technologies, and it is also a catalyst for attaining permits in each state in a more timely manner. The Company plans to accelerate its development efforts as this designation is an important factor for its potential energy partners.

In a proactive approach, the Company requested the EPA determine whether N-Viro Fuel qualifies within current regulations as an alternative fuel product, as opposed to a waste product that would be subject to incineration. The result of its request was the receipt of a written determination from the EPA that N-Viro Fuel qualifies as an alternative fuel.

The EPA sets forth various and stringent regulations for technologies such as N-Viro Fuel to qualify as alternative fuel. These regulations encompass three different regulatory divisions: water, air and solid waste. The N-Viro Fuel technology, utilizing an alkaline/heat process to produce a fuel product, satisfies all requirements of the EPA 40 CFR part 503 regulations and can be blended with coal for energy production or land applied for agricultural use as N-Viro Soil(TM). The Company's technologies can convert waste products that traditionally are landfilled, into safe, beneficial and renewable long-term energy solutions.

Timothy Kasmoch, CEO and Preside
'/>"/>

SOURCE N-Viro International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. N-Viro International Corporation Announces Dismissal of Lawsuit Against It
2. Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $1.00 Per Share
3. BioSpace and the Massachusetts Biotechnology Council Inc. Launch 2009 Genetown™ Hotbed Campaign
4. Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease
5. Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology
6. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
7. Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
8. ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology
9. MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDoses Electronic Dry Powder Inhaler
10. Sigma-Aldrich Acquires Seppro(R) Depletion Technology From GenWay Biotech
11. New one-of-a-kind technology will fly on 2 NASA missions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Baylor Research Institute (BRI) at Dallas ... in Phoenix, AZ , today announce an ... for patients with a broad range of cancers. Aligning the ... trials and access to technology to drive the development of ... across Baylor Scott & White Health,s 49 hospitals ...
(Date:5/21/2015)... N.J. (PRWEB) May 21, 2015 ... circulation audit and been admitted to BPA Worldwide ... BPA Worldwide will track audience data for Specialty ... coverage. , “By becoming a member of ... dedication to providing our clients with the most ...
(Date:5/21/2015)... 21, 2015 uBiome, the leading ... partnership with PicnicHealth, a healthcare company that collects ... with Inflammatory Bowel Disease (IBD) will receive a ... uBiome research kit. Both companies were funded by ... , For more information on this partnership and ...
(Date:5/21/2015)... Worms, Germany (PRWEB) May 21, 2015 ... announces that its manufacturing facility in Worms, Germany ... EXCiPACT™, an independent subsidiary of the International Pharmaceutical ... three Grace facilities that produce its SYLOID® FP ... now received GMP certification, following the Curtis Bay, ...
Breaking Biology Technology:Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Specialty Pharmacy Times Joins BPA Worldwide 2uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2
... Nov. 25 /PRNewswire/ - The Atlantica BioEnergy Task Force ... with political, business and education leaders from across Atlantic ... the forestry sector. , "The global forest ... all stakeholders to look for environmentally sustainable ways to ...
... 25 BioMarin Pharmaceutical,Inc. (Nasdaq: BMRN ) today ... a company update at the Piper,Jaffray Healthcare Conference in New ... , Interested parties may ... investor section of the BioMarin website, http://www.BMRN.com . A,replay ...
... Meet Dr. David Onslow, owner of,Excellon, a biotech company ... his team of scientists rise to the top with the ... about a,mysterious night in the 1970s when he witnessed a ... his wife Kate, and a team of doctors at,the foot ...
Cached Biology Technology:Atlantica Bioenergy Task Force hosts industry and government leaders 2Atlantica Bioenergy Task Force hosts industry and government leaders 3BioMarin to Present at the Piper Jaffray Healthcare Conference 2'Far From Beyond': A Glimpse into the World of Biotechnology and the Future of the Free World 2
(Date:5/14/2015)... 2015  Verificient Technologies, Inc., a technology ... remote proctoring, announced a new alliance partnership ... creator of the Canvas Learning Management System ... will benefit from the seamless integration of ... a fully integrated multifactor biometrics behavioral application, ...
(Date:5/11/2015)... 2015  Through a well-rounded UAS delegation representing private industry, ... strong showing at AUVSI,s Unmanned 2015 conference last week in ... Ohio,s UAS industry met with over 200 hundred ... along the UAS ecosystem. "Our message is ... for Aerospace Rich Knoll . "If you want to ...
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... unknown mechanism in the body which regulates a hormone ... of blood pressure, pain and appetite. The breakthrough could ... problems connected with these functions in the future. ... London found that lactate essentially lactic acid ...
... scientists at King,s College London have identified a gene linking ... intelligence. The study is published today in Molecular Psychiatry ... forms of intellectual impairment. The researchers looked at ... It is known as ,grey matter, and plays a key ...
... used to treat breast cancer, also kills a fungus that ... findings, which could lead to new treatments for a disease ... mBio , the online open-access journal of the American Society ... additional animal studies to see if tamoxifen can be used ...
Cached Biology News:New research sheds light on how the body regulates fundamental neuro-hormone 2Scientists identify gene linking brain structure to intelligence 2Breast cancer drug fights fungal disease 2
X-Gal, 1 g. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzymes...
Recombinant Rat Fas Ligand/TNFSF6...
Request Info...
FGF Receptor 1 Antibody...
Biology Products: